Profund Advisors LLC Haemonetics Corp Transaction History

Profund Advisors LLC

  • $2.59 Billion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$71.24 - $85.35 $8,620 - $10,327
121 Added 4.37%
2,889 $246,000
Q4 2023

Feb 14, 2024
BUY
$80.59 - $92.61 $27,722 - $31,857
344 Added 14.19%
2,768 $236,000
Q3 2023

Nov 13, 2023
SELL
$82.56 - $93.49 $12,961 - $14,677
-157 Reduced 6.08%
2,424 $217,000
Q2 2023

Aug 10, 2023
SELL
$80.84 - $89.45 $9,862 - $10,912
-122 Reduced 4.51%
2,581 $219,000
Q1 2023

May 11, 2023
SELL
$72.75 - $90.6 $49,688 - $61,879
-683 Reduced 20.17%
2,703 $223,000
Q4 2022

Feb 02, 2023
SELL
$73.85 - $86.14 $13,514 - $15,763
-183 Reduced 5.13%
3,386 $266,000
Q3 2022

Nov 04, 2022
SELL
$63.3 - $78.66 $13,419 - $16,675
-212 Reduced 5.61%
3,569 $264,000
Q2 2022

Aug 01, 2022
SELL
$49.27 - $66.08 $62,572 - $83,921
-1,270 Reduced 25.14%
3,781 $246,000
Q1 2022

May 10, 2022
BUY
$43.77 - $63.22 $18,120 - $26,173
414 Added 8.93%
5,051 $319,000
Q4 2021

Feb 08, 2022
BUY
$49.55 - $74.59 $6,292 - $9,472
127 Added 2.82%
4,637 $246,000
Q3 2021

Nov 12, 2021
SELL
$57.6 - $70.59 $22,060 - $27,035
-383 Reduced 7.83%
4,510 $318,000
Q2 2021

Aug 12, 2021
BUY
$51.81 - $118.56 $77,766 - $177,958
1,501 Added 44.25%
4,893 $326,000
Q1 2021

May 14, 2021
SELL
$111.01 - $139.48 $26,309 - $33,056
-237 Reduced 6.53%
3,392 $377,000
Q4 2020

Feb 09, 2021
SELL
$88.75 - $119.95 $8,431 - $11,395
-95 Reduced 2.55%
3,629 $431,000
Q3 2020

Nov 13, 2020
BUY
$75.65 - $93.58 $56,283 - $69,623
744 Added 24.97%
3,724 $325,000
Q2 2020

Aug 03, 2020
SELL
$84.96 - $118.91 $22,599 - $31,630
-266 Reduced 8.19%
2,980 $267,000
Q1 2020

May 15, 2020
SELL
$74.34 - $121.82 $191,574 - $313,930
-2,577 Reduced 44.26%
3,246 $323,000
Q4 2019

Feb 18, 2020
BUY
$114.37 - $129.46 $45,748 - $51,784
400 Added 7.38%
5,823 $669,000
Q3 2019

Nov 12, 2019
SELL
$117.16 - $138.52 $137,780 - $162,899
-1,176 Reduced 17.82%
5,423 $684,000
Q2 2019

Aug 13, 2019
SELL
$81.74 - $120.34 $30,407 - $44,766
-372 Reduced 5.34%
6,599 $794,000
Q1 2019

May 15, 2019
BUY
$83.25 - $102.12 $131,701 - $161,553
1,582 Added 29.36%
6,971 $610,000
Q4 2018

Feb 14, 2019
SELL
$90.66 - $116.63 $242,878 - $312,451
-2,679 Reduced 33.21%
5,389 $539,000
Q3 2018

Nov 13, 2018
SELL
$89.96 - $114.58 $17,362 - $22,113
-193 Reduced 2.34%
8,068 $924,000
Q2 2018

Aug 13, 2018
SELL
$71.53 - $95.75 $197,923 - $264,940
-2,767 Reduced 25.09%
8,261 $741,000
Q1 2018

May 14, 2018
BUY
$60.72 - $74.41 $112,210 - $137,509
1,848 Added 20.13%
11,028 $807,000
Q4 2017

Feb 14, 2018
SELL
$44.96 - $58.99 $16,185 - $21,236
-360 Reduced 3.77%
9,180 $533,000
Q3 2017

Nov 13, 2017
SELL
$40.38 - $44.87 $29,719 - $33,024
-736 Reduced 7.16%
9,540 $428,000
Q2 2017

Aug 11, 2017
BUY
N/A
10,276
10,276 $406,000

Others Institutions Holding HAE

# of Institutions
333
Shares Held
54M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email